Assistant Professor, Medicine, University of Minnesota Medical School
Hematology
Dr. Mark T. Reding, MD
|
|
Give Review
Mark T. Reding, MD is an expert in the field of Hematology. He went to University of Minnesota Medical School. University of Minnesota Medical School is ranked 40/10 in Research/PrimaryCare. He received awards:"Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Mark Reding is also a published doctor. He has 25 publication published. The most recent publication is: Diagnosis and outcome of 100 consecutive patients with extreme granulocytic leukocytosis. Mark Reding accepts Medicare payments and is registered with Medicare.gov.
Publications
- Hemorrhagic cystitis after allogeneic hematopoietic Cell transplantation: risk factors, graft source and survival.
- Anti-Factor Xa and Activated Partial Thromboplastin Time Measurements for Heparin Monitoring in Mechanical Circulatory Support.
- Monitoring antiCoagulation in patients with an unreliable prothrombin time/international normalized ratio: factor II versus chromogenic factor X testing.
- Management of Bleeding Associated with Dabigatran and Rivaroxaban: A Survey of Current Practices.
- Is prophylaxis required for deLivery in women with factor VII deficiency?
- Case studies in the management of refractory bleeding in patients with haemophilia A and inhibitors.
- Barriers to effective diagnosis and management of a bleeding patient with undiagnosed bleeding disorder across multiple specialties: results of a quantitative case-bas...
- Patient- and caregiver-reported bleeding symptoms and reasons for starting and stopping treatment with recombinant factor VIIa: Analysis of the Dosing Observational St...
- Hemophilic arthropathy of the elbow.
- Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of Hemophilia A mice.
- Use of recombinant human antithrombin concentrate in pregnancy.
- Diagnosis and outcome of 100 consecutive patients with extreme granulocytic Leukocytosis.
- Inhibitor development.
- Immunological aspects of inhibitor development.
- Human CD4+ T-cell epitope repertoire on the C2 domain of Coagulation factor VIII.
- Successful Liver transplantation in a patient with severe haemophilia A and a high-titre factor VIII inhibitor.
- Thrombotic stroke associated with the use of porcine factor VIII in a patient with acquired haemophilia.
- Epitope repertoire of human CD4(+) T cells on the A3 domain of Coagulation factor VIII.
- CD4+ T cells specific for factor VIII as a target for specific suppression of inhibitor proDuction.
- Mechanism of the immune response to human factor VIII in murine Hemophilia A.
- Sensitization of CD4+ T cells to Coagulation factor VIII: response in congenital and acquired hemophilia patients and in healthy subjects.
- CD4+ T cell response to factor VIII in Hemophilia A, acquired Hemophilia, and healthy subjects.
- Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired Hemophilia patients.
- Red cell aplasia and autoimmune hemolytic Anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients.
Schools
University Of Minnesota Medical School
University Minn Hosps
Va Med Center University Minn
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
University of Minnesota -
University of Minnesota Medical School
Hospital
-
University of Minnesota Medical Center, Fairview
Drug Facts
| NPI NUMBER | 1336223866 | |
| NPPES Provider LastName | REDING | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 554550341 | |
| NPPES Provider State | MN | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 393.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 3.05 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1336223866 |
| Last Name Of The Provider | REDING |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
|
Dr. Mark R. Menge, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dean H. Gesme, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles F. Moldow, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Hector A. Mesa-Corrales, MD |
|
|
Dr. Betul Oran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert T. Perri, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Venkatesh K. Rudrapatna, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Punit D. Wadhwa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Linden, MD
This Doctor is OpenDoctor Recommended.
|